Our #1 trading idea for Friday was SRPT. It sold $300 million of shares in a secondary offering via Goldman Sachs and JP Morgan. Normally, biotech secondaries are excellent long set ups. The prior week I had been long AERI following its secondary offering and it traded 30%+ higher in a few days. But this time was different. I discussed why SRPT was likely a good short … Read More
Trading That Crazy SRPT
The most In Play stock this morning was SRPT. It is one of the crazier liquid biotech names from a price action standpoint to ever to grace our markets. Because of the strength of the news catalyst and the size of the reaction this morning it was at the top of our AM Game Plan. I decided for fun to poll … Read More